Lectins CGL and MTL, representatives of mytilectin family, exhibit different antiproliferative activity in Burkitt's lymphoma cells.
antiproliferative activity
apoptosis
bivalve lectins
cell cycle
computer modeling
Journal
IUBMB life
ISSN: 1521-6551
Titre abrégé: IUBMB Life
Pays: England
ID NLM: 100888706
Informations de publication
Date de publication:
21 Aug 2024
21 Aug 2024
Historique:
received:
14
05
2024
accepted:
16
07
2024
medline:
21
8
2024
pubmed:
21
8
2024
entrez:
21
8
2024
Statut:
aheadofprint
Résumé
Lectins are carbohydrate-binding proteins, whose biological effects are exerted via binding to glycoconjugates expressed on the surface of cells. Exposure to lectins can lead not only to a change in the structure and properties of cells but also to their death. Here, we studied the biological activity of lectins from the mussels Crenomytilus graynus (CGL) and Mytilus trossulus (MTL) and showed that these proteins can affect the proliferation of human lymphoma cells. Both lectins suppressed the formation of colonies as well as cell cycle progression. The mechanism of action of these lectins was not mediated by reactive oxygen species but included damaging of mitochondria, inhibition of key cell cycle points, and activation of MAPK signaling pathway in tumor cells. Computer modeling suggested that various effects of CGL and MTL on lymphoma cells may be due to the difference in the energy of binding of these lectins to carbohydrate ligands on the cell surface. Thus, molecular recognition of residues of terminal carbohydrates on the surface of tumor cells is a key factor in the manifestation of the biological action of lectins.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 International Union of Biochemistry and Molecular Biology.
Références
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249.
Sturgeon RJ. Carbohydrates. Encyclopedia of life sciences. London: Nature Publishing Group; 2003.
Dennis JW, Granovsky M, Warren CE. Protein glycosylation in development and disease. BioEssays. 1999;21:412–421.
Sharon N. Lectins: carbohydrate‐specific reagents and biological recognition molecules. J Biol Chem. 2007;282:2753–2764.
Ambrosi M, Cameron NR, Davis BG. Lectins: tools for the molecular understanding of the glycocode. Org Biomol Chem. 2005;3:1593–1608.
Kilpatrick DC. Animal lectins: a historical introduction and overview. Biochim Biophys Acta. 2002;1572:187–197.
Liu Z, Zhang Q, Peng H, Zhang WZ. Animal lectins: potential antitumor therapeutic targets in apoptosis. Appl Biochem Biotechnol. 2012;168:629–637.
Akkouh O, Ng TB, Singh SS, Yin C, Dan X, Chan YS, et al. Lectins with anti‐HIV activity: a review. Molecules. 2015;20:648–668.
Yau T, Dan X, Ng CC, Ng TB. Lectins with potential for anti‐cancer therapy. Molecules. 2015;20:3791–3810.
Przybyło M, Hoja‐Lukowicz D, Lityńska A, Laidler P. Different glycosylation of cadherins from human bladder non‐malignant and cancer cell lines. Cancer Cell Int. 2002;2:1–5.
Varki A, Kannagi R, Toole B, Stanley P. Glycosylation changes in cancer. In: Varki A, Cummings RD, Esko JD, editors. Essentials of glycobiology. Cold Spring, NY: Harbor; 2015. p. 597–609.
Ogawa T, Watanabe M, Naganuma T, Muramoto K. Diversified carbohydrate‐binding lectins from marine resources. J Amino Acids. 2011;2011:1–20.
Luk'yanov PA, Chernikov OV, Kobelev SS, Chikalovets IV, Molchanova VI, Li W. Carbohydrate‐binding proteins of marine invertebrates. Bioorg Khim. 2007;33:172.
Molchanova V, Chernikov O, Chikalovets I, Lukyanov P. Purification and partial characterization of the lectin from the marine red alga Tichocarpus crinitus (Gmelin) Rupr. (Rhodophyta). Bot Mar. 2010;53:69–78.
Chernikov OV, Molchanova VI, Chikalovets IV, Kondrashina AS, Li W, Lukyanov PA. Lectins of marine hydrobionts. Biochem Mosc. 2013;78:760–770.
Belogortseva NI, Molchanova VI, Kurika AV, Skobun AS, Glazkova VE. Isolation and characterization of new GalNAc/gal‐specific lectin from the sea mussel Crenomytilus grayanus. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1998;119:45–50.
Chikalovets IV, Kondrashina AS, Chernikov OV, Molchanova VI, Luk'yanov PA. Isolation and general characteristics of lectin from the mussel Mytilus trossulus. Chem Nat Compd. 2013;48:1058–1061.
Kovalchuk SN, Chikalovets IV, Chernikov OV, Molchanova VI, Li W, Rasskazov VA, et al. CDNA cloning and structural characterization of a lectin from the mussel Crenomytilus grayanus with a unique amino acid sequence and antibacterial activity. Fish Shellfish Immunol. 2013;35:1320–1324.
Chikalovets IV, Kovalchuk SN, Litovchenko AP, Molchanova VI, Pivkin MV, Chernikov OV. A new gal/GalNAc‐specific lectin from the mussel Mytilus trossulus: structure, tissue specificity, antimicrobial and antifungal activity. Fish Shellfish Immunol. 2016;50:27–33.
Fujii Y, Dohmae N, Takio K, Kawsar SMA, Matsumoto R, Hasan I, et al. A lectin from the mussel Mytilus galloprovincialis has a highly novel primary structure and induces glycan‐mediated cytotoxicity of globotriaosylceramide‐expressing lymphoma cells. J Biol Chem. 2012;287:44772–44783.
Hasan I, Gerdol M, Fujii Y, Rajia S, Koide Y, Yamamoto D, et al. CDNA and gene structure of MytiLec‐1, A bacteriostatic R‐type lectin from the mediterranean mussel (Mytilus galloprovincialis). Mar Drugs. 2016;14:92.
García‐Maldonado E, Cano‐Sánchez P, Hernández‐Santoyo A. Molecular and functional characterization of a glycosylated galactose‐binding lectin from Mytilus californianus. Fish Shellfish Immunol. 2017;66:564–574.
Chikalovets I, Filshtein A, Molchanova V, Mizgina T, Lukyanov P, Nedashkovskaya O, et al. Activity dependence of a novel lectin family on structure and carbohydrate‐binding properties. Molecules. 2019;25:150.
Gerdol M, Nerelli DE, Martelossi N, Ogawa Y, Fujii Y, Pallavicini A, et al. Taxonomic distribution and molecular evolution of mytilectins. Mar Drugs. 2023;21(12):614.
Chernikov O, Kuzmich A, Chikalovets I, Molchanova V, Hua K‐F. Lectin CGL from the sea mussel Crenomytilus grayanus induces Burkitt's lymphoma cells death via interaction with surface glycan. Int J Biol Macromol. 2017;104:508–514.
Cory AH, Owen TC, Barltrop JA, Cory JG. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun. 1991;3:207–212.
Dyshlovoy SA, Rast S, Hauschild J, Otte K, Alsdorf WH, Madanchi R, et al. Frondoside a induces AIF‐associated caspase‐independent apoptosis in Burkitt lymphoma cells. Leuk Lymphoma. 2017;58:2905–2915.
Borowicz S, Van Scoyk M, Avasarala S, Rathinam MKK, Tauler J, Bikkavilli RK, et al. The soft agar colony formation assay. J Vis Exp. 2014;27:51998.
Liao J‐H, Chien C‐TH, Wu H‐Y, Huang K‐F, Wang I, Ho M‐R, et al. A multivalent marine lectin from Crenomytilus grayanus possesses anti‐cancer activity through recognizing globotriose Gb3. J Am Chem Soc. 2016;138:4787–4795.
Nudelman E, Kannagi R, Hakomori S, Parsons M, Lipinski M, Wiels J, et al. A glycolipid antigen associated with Burkitt lymphoma defined by a monoclonal antibody. Science. 1983;220:509–511.
Norbury C, Blow J, Nurse P. Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates. EMBO J. 1991;10:3321–3329.
Liu Z, Luo Y, Zhou T‐T, Zhang W‐Z. Could plant lectins become promising anti‐tumour drugs for causing autophagic cell death? Cell Prolif. 2013;46:509–515.
Cardoso MRD, Mota CM, Ribeiro DP, Noleto PG, Andrade WBF, Souza MA, et al. Adjuvant and immunostimulatory effects of a d‐galactose‐binding lectin from Synadenium carinatum latex (ScLL) in the mouse model of vaccination against neosporosis. Vet Res. 2012;43:1–13.
Balzarini J. Carbohydrate‐binding agents: a potential future cornerstone for the chemotherapy of enveloped viruses? Antivir Chem Chemother. 2007;18:1–11.
Wu L, Yang X, Duan X, Cui L, Li G. Exogenous expression of marine lectins DlFBL and SpRBL induces cancer cell apoptosis possibly through PRMT5‐E2F‐1 pathway. Sci Rep. 2014;4:4505.
Carrizo ME, Capaldi S, Perduca M, Irazoqui FJ, Nores GA, Monaco HL. The antineoplastic lectin of the common edible mushroom (Agaricus bisporus) has two binding sites, each specific for a different configuration at a single epimeric hydroxyl. J Biol Chem. 2005;280:10614–10623.
Bovi M, Cenci L, Perduca M, Capaldi S, Carrizo ME, Civiero L, et al. BEL β‐trefoil: a novel lectin with antineoplastic properties in king bolete (boletus edulis) mushrooms. Glycobiology. 2013;23:578–592.
Kawano T, Sugawara S, Hosono M, Tatsuta T, Ogawa Y, Fujimura T, et al. Globotriaosylceramide‐expressing Burkitt's lymphoma cells are committed to early apoptotic status by rhamnose‐binding lectin from catfish eggs. Biol Pharm Bull. 2009;32:345–353.
Khan FI, Wei DQ, Gu KR, Hassan MI, Tabrez S. Current updates on computer aided protein modeling and designing. Int J Biol Macromol. 2016;85:48–62.
Miyamoto D, Ueno T, Takashima S, Ohta K, Miyawaki T, Suzuki T, et al. Establishment of a monoclonal antibody directed against Gb3Cer/CD77: a useful immunochemical reagent for a differentiation marker in Burkitt's lymphoma and germinal centre B cells. Glycoconj J. 1997;14:379–388.
Hasan I, Sugawara S, Fujii Y, Koide Y, Terada D, Iimura N, et al. MytiLec, a mussel R‐type lectin, interacts with surface glycan Gb3 on Burkitt's lymphoma cells to trigger apoptosis through multiple pathways. Mar Drugs. 2015;13:7377–7389.
Del Rio M, de la Canal L, Pinedo M, Regente M. Internalization of a sunflower mannose‐binding lectin into phytopathogenic fungal cells induces cytotoxicity. J Plant Physiol. 2018;221:22–31.
Fujii Y, Fujiwara T, Koide Y, Hasan I, Sugawara S, Rajia S, et al. Internalization of a novel, huge lectin from ibacus novemdentatus (slipper lobster) induces apoptosis of mammalian cancer cells. Glycoconj J. 2017;34:85–94.
Tilsed CM, Fisher SA, Nowak AK, Lake RA, Lesterhuis WJ. Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action. Front Oncol. 2022;12:960317.
Shapiro GI, Harper JW. Anticancer drug targets: cell cycle and checkpoint control. J Clin Invest. 1999;104:1645–1653.
Sakaue‐Sawano A, Kobayashi T, Ohtawa K, Miyawaki A. Drug‐induced cell cycle modulation leading to cell‐cycle arrest, nuclear mis‐segregation, or endoreplication. BMC Cell Biol. 2011;12:1–12.
Lorca T, Labbé JC, Devault A, Fesquet D, Capony JP, Cavadore JC, et al. Dephosphorylation of cdc2 on threonine 161 is required for cdc2 kinase inactivation and normal anaphase. EMBO J. 1992;11:2381–2390.
Atherton‐Fessler S, Liu F, Gabrielli B, Lee MS, Peng CY, Piwnica‐Worms H. Cell cycle regulation of the p34(cdc2) inhibitory kinases. Mol Biol Cell. 1994;5:989–1001.
Jessus C, Ozon R. Function and regulation of cdc25 protein phosphate through mitosis and meiosis. Prog Cell Cycle Res. 1995;1:215–228.
Blasina A, Van de Weyer I, Laus MC, Luyten WHML, Parker AE, McGowan CH. A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase. Curr Biol. 1999;9:1–10.
Zhao H, Piwnica‐Worms H. ATR‐mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol Cell Biol. 2001;21:4129–4139.
Zeng Y, Forbes KC, Wu Z, Moreno S, Piwnica‐Worms H, Enoch T. Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1. Nature. 1998;395:507–510.
Tian C, Liu Y, Li Z, Zhu P, Zhao M. Mitochondria related cell death modalities and disease. Front Cell Dev Biol. 2022;10:832356.
Van Loo G, Saelens X, Van Gurp M, MacFarlane M, Martin SJ, Vandenabeele P. The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ. 2002;9(10):1031–1042.
Tait SWG, Green DR. Caspase‐independent cell death: leaving the set without the final cut. Oncogene. 2008;27:6452–6461.
Lorenzo HK, Susin SA, Penninger J, Kroemer G. Apoptosis inducing factor (AIF): a phylogenetically old, caspase‐independent effector of cell death. Cell Death Differ. 1999;6:516–524.
Villegas‐Coronado D, Soto‐Guzman JA, Martínez‐Soto JM, Teran‐Saavedra NG, Guzman‐Partida AM, Vazquez‐Moreno L, et al. Antiproliferative potential of olneya tesota PF2 lectin in human acute monocytic leukemia cells. Chem Biodivers. 2023;20:1–8.
Kim WH, Park WB, Gao B, Jung MH. Critical role of reactive oxygen species and mitochondrial membrane potential in korean mistletoe lectin‐induced apoptosis in human hepatocarcinoma cells. Mol Pharmacol. 2004;66:1383–1396.
Tatsuta T, Hosono M, Sugawara S, Kariya Y, Ogawa Y, Hakomori S, et al. Sialic acid‐binding lectin (leczyme) induces caspase‐dependent apoptosis‐mediated mitochondrial perturbation in jurkat cells. Int J Oncol. 2013;43:1402–1412.
Bavaria MN, Jin S, Ray RM, Johnson LR. The mechanism by which MEK/ERK regulates JNK and p38 activity in polyamine depleted IEC‐6 cells during apoptosis. Apoptosis. 2014;19:467–479.
Wang Y, De Chen A, Lei YM, Shan GQ, Zhang LY, Lu X, et al. Mannose‐binding lectin inhibits monocyte proliferation through transforming growth factor‐β1 and p38 signaling pathways. PLoS One. 2013;8:1–12.
Tamma SML, Kalyanaraman VS, Pahwa S, Dominguez P, Modesto RR. The lectin jacalin induces phosphorylation of ERK and JNK in CD4+ T cells. J Leukoc Biol. 2003;73:682–688.
Yue J, López JM. Understanding MAPK signaling pathways in apoptosis. Int J Mol Sci. 2020;21:1–22.
Chambard JC, Lefloch R, Pouysségur J, Lenormand P. ERK implication in cell cycle regulation. Biochim Biophys Acta. 2007;1773:1299–1310.
Munshi A, Hobbs M, Meyn RE. Clonogenic cell survival assay. Methods Mol Med. 2005;110:21–28.
Poiroux G, Barre A, van Damme EJM, Benoist H, Rougé P. Plant lectins targeting O‐glycans at the cell surface as tools for cancer diagnosis, prognosis and therapy. Int J Mol Sci. 2017;18:1232.
Srinivas BK, Shivamadhu MC, Jayarama S. Musa acuminata lectin exerts anti‐cancer effects on HeLa and EAC cells via activation of caspase and inhibitions of Akt, Erk, and Jnk pathway expression and suppresses the neoangiogenesis in in‐vivo models. Int J Biol Macromol. 2021;166:1173–1187.